EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-15478 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr2:225758290-225760420 
TF binding sites/motifs
Number: 9             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
FOXA1MA0148.4chr2:225760118-225760134AATTATTTACATAATC-6.02
MAFGMA0659.1chr2:225758473-225758494ATTTTGCAGTCTCAGCAACTC-6.02
NFAT5MA0606.1chr2:225758312-225758322ATTTTCCATT+6.02
NFATC1MA0624.1chr2:225758312-225758322ATTTTCCATT+6.02
NFATC3MA0625.1chr2:225758312-225758322ATTTTCCATT+6.02
Rhox11MA0629.1chr2:225759026-225759043TTTCTTTACAGCATCAT-6.08
SPI1MA0080.4chr2:225759221-225759235AGAAAGAGGAAGTC+6.21
SPICMA0687.1chr2:225759221-225759235AGAAAGAGGAAGTC+6.67
Sox6MA0515.1chr2:225758971-225758981CCATTGTTTT+6.02
Number of super-enhancer constituents: 2             
IDCoordinateTissue/cell
SE_11129chr2:225757515-225763655CD20
SE_18264chr2:225757474-225760548CD4p_CD25-_Il17-_PMAstim_Th
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 3             
ChromosomeStartEnd
chr2225758480225759400
chr2225759181225759393
chr2225759100225759430
Number: 1             
IDChromosomeStartEnd
GH02I224893chr2225758527225760539
Enhancer Sequence
TTCCTAGTGT GTAAAGGCTT ACATTTTCCA TTCTAGCCTG AAGTCATCTA TTTCTTCAGT 60
ATCTTCCTAT GGACCCTCGC TTAAAAATAA AAAAAGTGAA AATCTTAAGA GTCAATAATA 120
CACATTTAAA TTTAAAGAAT AAATTTCACC TTTTTTTTTG CTTTTCTATA ATTGCAAATT 180
TTCATTTTGC AGTCTCAGCA ACTCATAAAA AGAAATAAGC AATTTAAATT GGTAGCAGAC 240
ATAGGAGAAT TCTTCTAATC CAGGAGGTAT GAAAATGATT TACTTCTATT AGCCTCGGAA 300
GACCCAAGTA AATTGTCTGT TTCCATTACT GACCTAAATA CATGTAGTCT TTAGAGGGGA 360
ATGCTTAGCT TTGTAAAATC ATTTTAAAGA ATAATTCTGC TGTTCAGTGC TCATCTTCAT 420
TGTTCTGGGG TATATCTGAA AGGGTTATAT TTTTGAACTT CTGATTTTCA GTTTGAATAC 480
ATAAAGTTTC TTACTTTGTG GCAGTCTGAT TCTTCCCTTT CTTGGTATTA ACTTCCACTT 540
TCTTTAGTTA AAGTAAGGGA AATTCTCAAC AATACTTCAG TTAATTTTTT TTATTTCTTC 600
TCATGAGATT AATCTTGCAA ACTATGAGAA TTGCAATTAA GCAATAATGT CCGGGATTGG 660
TTTTTTCTAG AGATGCTTTC TCCATTGTTT TAACAGAGGA AGAATACTGT GAATGTGAAA 720
TCTCTAATTT GCTTTCTTTC TTTACAGCAT CATGAATATA AGGAAAGATG AACAGTGTTT 780
GGGGATACAG CCACTGAAGA GTGTAATGGA CCTAAAGATG GTGGGAACAC ATTTAGTTAA 840
AAGGATGGCT AAATACGGCT GTCTCCATCC TCTCAACTTG AGATGCAGTC TCCCAACTTC 900
CGAGTTGTAA CCACTTCTCA GAACTATTTT CAGAAAGAGG AAGTCCTGAT GTTAAAAGAT 960
GCTTTGCTTT TCAGTTGTGC CTACAAAAAC TGTGTCATGA ACACCCAGAC ATTCTGAATG 1020
TAACAATTAC TCATGAAAGC TTAGGGTGTG GTAAACCTTC CCAACATGAA GTTGCAAGAG 1080
CTTGTCTATC AGCAGGGATT CAAGTCAAAA AGAATGCTCA AAGATCTGGT AAACGTTACT 1140
GTTCAGTGTT TTGAAAAAAG ATTTGCAGTT TAGAAGGGAC ATACTTTTTT TCTCTTCACG 1200
GTAATGAAAC CCCAAAATAA ATGGCCTCCT CCTGTCTTTT TCTTCGATTG CCACCCCTGC 1260
AGTCCCATTC TCCATAGAGT AGCCCAAGAG TTCTTTCAAA GAGGTAAACC AGATCATGCC 1320
ACACCCCTGG TTGAAATTTC CAAAGGCTTT TGTTGCAATG AAAGTAAAAT CCAAGCTCCT 1380
TTCCAGGGCA CACAGGGTCC CTTGCCTAAG GTCCTTGGTT TCATCTTATT ACGCCCCTTT 1440
CATCCTTAAG CTCTAGCCTT CCTGACTCAA GTGACCATAC TGGTTCCCAC CACTTCAGGG 1500
TCTTTGCCTT GCTGCTTCTC CAGAATCCTT TCCCAAGATG CCTGTGTTGG CAGCTACTGC 1560
CGATTCATAT CCAAGATCAA ATGTCACCTT CTTAAATCTA GTTCATAATC CCTCTTTCAA 1620
ATTCCGCATT CGGAAATTGA GAGCAATGCT TCCAAGTATA CAAGTCTTGA AAAGGTGCTT 1680
CTGGGGCCAC AGGAAATATA GCAAAGTGGT TCCCAATTCT GTACCATGTG TCTATTAAAA 1740
ATTAGATCCA ATGTGTATCA TATCAGTGCT TCACTTGAGG AGAGTGTTAA TACAAACTTA 1800
ACTTTTGATT GTTTCAAGTG TTTTTCTGAA TTATTTACAT AATCTTAGCT TGATGAACCA 1860
GTGAGTTGGG TAGAACCAGT TCAAGGAAGT TCTTTAAATA TGAGCAACTC CAAACCCATC 1920
CAGGAATATT ATATTTTAAA ATTTGCCATT TACTCTGTTT GTTCGTCCAA TAAGTAATTA 1980
TAGTACTGCA CACCTACTAT GTGCCAGGCA TTCTTCTTAC AGGCCTGCAG GGGATTCTGC 2040
AGGGAAAAGT CCCTGCCCTT TGGGGATTTT TACTTTAGAA GGGGAAACAG ACACTGAATT 2100
AATTTCTATT TTTGTTCAGG TAGTCAGGTG 2130